Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.16 USD | +1.08% | -10.73% | -10.29% |
Apr. 18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
Apr. 17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.29% | 4.77B | |
-1.82% | 41.35B | |
+42.38% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Stifel Adjusts CRISPR Therapeutics' Price Target to $55 from $57, Keeps Hold Rating